Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 05-2023 | 02-2023 | 11-2022 | 08-2022 | 05-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,140 | -5,348 | -3,698 | -2,072 | -4,531 |
| Depreciation Amortization | 351 | 268 | 182 | 96 | 595 |
| Accounts receivable | -291 | 155 | -445 | -388 | 1,365 |
| Other Working Capital | -38 | -263 | -189 | -267 | 3,600 |
| Other Operating Activity | 1,644 | 677 | 1,364 | 1,058 | -1,508 |
| Operating Cash Flow | $-5,474 | $-4,511 | $-2,786 | $-1,573 | $-479 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -64 | -64 | -58 | -34 | -57 |
| Purchase Sale Intangibles | -14 | N/A | N/A | N/A | -113 |
| Other Investing Activity | -14 | 0 | 0 | 0 | -113 |
| Investing Cash Flow | $-78 | $-64 | $-58 | $-34 | $-170 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,095 | 2,093 | 2,067 | 1,825 | 2,479 |
| Other Financing Activity | -705 | -53 | -52 | -47 | -85 |
| Financing Cash Flow | $9,390 | $2,040 | $2,015 | $1,778 | $2,394 |
| Exchange Rate Effect | -36 | -37 | -21 | -13 | -26 |
| Beginning Cash Position | 5,917 | 5,917 | 5,917 | 5,917 | 4,199 |
| End Cash Position | 9,719 | 3,345 | 5,067 | 6,075 | 5,917 |
| Net Cash Flow | $3,802 | $-2,572 | $-850 | $158 | $1,719 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,474 | -4,511 | -2,786 | -1,573 | -479 |
| Capital Expenditure | -64 | -64 | -58 | -34 | -57 |
| Free Cash Flow | -5,538 | -4,575 | -2,844 | -1,607 | -536 |